| | Nutra Pharma Sponsors Educational Website for Adrenomyelonueropathy (AMN) - Health - RedOrbit |
 | | "Although there is currently no approved treatment for AMN, we felt that it is important to educate patients about this disease and to provide information about current treatment research," explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. |
 | | "AMN is a rare inherited metabolic disorder, but still interests the wider neurologic community because of its similarities to Multiple Sclerosis," commented Stewart Lonky, MD, a member of the board of directors of Nutra Pharma Corporation. |
 | | "AMN is often misdiagnosed and confused with Multiple Sclerosis and it is our hope that the AMNhelp.com website will help educate the public about the differences between the two diseases," he concluded. |
| www.redorbit.com /news/health/803385/nutra_pharma_sponsors_educational_website_for_adrenomyelonueropathy_amn/index.html?source=r_health (588 words) |